Imaging in primary penile cancer: current status and future directions

被引:0
|
作者
Rohit Kochhar
Ben Taylor
Vijay Sangar
机构
[1] The Christie,Department of Radiology
[2] NHS Foundation Trust,Department of Urology
[3] The Christie,undefined
[4] NHS Foundation Trust,undefined
来源
European Radiology | 2010年 / 20卷
关键词
Penile cancer; Magnetic resonance imaging; Computed tomography; Ultrasound; Sentinel lymph node;
D O I
暂无
中图分类号
学科分类号
摘要
Penile cancer is a rare neoplasm in the developed world. Clinical assessment often results in inaccurate staging and radiological techniques have a key role in staging and postoperative assessment. Magnetic resonance imaging (MRI) depicts penile anatomy in detail and is the most accurate technique for local staging and postoperative follow-up. MRI and ultrasound (US), although helpful for assessment of lymph nodes, are not reliable enough for accurate nodal staging. US-guided fine needle aspiration cytology (FNAC), however, remains a valuable tool to confirm metastases in suspicious inguinal nodes. Lymphoscintigraphy with dynamic sentinel node biopsy (DSNB) is a promising technique used to predict occult lymph node metastases. Novel imaging techniques such as positron emission tomography/computed tomography (PET-CT) and nanoparticle enhanced MRI have high sensitivity and specificity for lymph node metastases but their availability is limited and clinical utility is not fully established. The radiologist needs to be familiar with the normal penile anatomy, imaging appearances of pre- and post-treatment penile cancer, and the advantages and limitations of the available imaging techniques. This review highlights the above points and presents a systematic approach to make the best use of imaging in the management of patients with penile cancer.
引用
收藏
页码:36 / 47
页数:11
相关论文
共 50 条
  • [41] Chemoprevention of prostate cancer: Current status and future directions
    Lieberman, R
    CANCER AND METASTASIS REVIEWS, 2002, 21 (3-4) : 297 - 309
  • [42] Management of pancreatic cancer: Current status and future directions
    Ramesh, H.
    INDIAN JOURNAL OF SURGERY, 2009, 71 (06) : 368 - 372
  • [43] Screening for Prostate Cancer: Current Status and Future Directions
    Gershman, Boris
    Karnes, R. Jeffrey
    EUROPEAN UROLOGY FOCUS, 2015, 1 (02): : 147 - 148
  • [44] Lung cancer chemoprevention: current status and future directions
    Jenny T. Mao
    Ravi Durvasula
    Current Respiratory Care Reports, 2012, 1 (1): : 9 - 20
  • [45] Virotherapy for cancer: Current status, hurdles, and future directions
    David Kirn
    Cancer Gene Therapy, 2002, 9 : 959 - 960
  • [46] Current Status and Future Directions in the Management of Pancreatic Cancer
    Are, Chandrakanth
    Patel, Asish
    INDIAN JOURNAL OF SURGICAL ONCOLOGY, 2015, 6 (01) : 3 - 5
  • [47] Ovarian cancer screening: Current status and future directions
    Nash, Zachary
    Menon, Usha
    BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2020, 65 : 32 - 45
  • [48] Colorectal cancer in Tanzania: the current status and future directions
    Akoko, Larry
    Brand, Nathan
    Kotecha, Vihar
    Byabato, Sam
    Ndumbalo, Jerry
    Mwashambwa, Masumbuko
    Mwakigonja, Amos
    Lowry, Ann
    ECANCERMEDICALSCIENCE, 2023, 17
  • [49] Management of Pancreatic Cancer: Current Status and Future Directions
    H. Ramesh
    Indian Journal of Surgery, 2010, 72 : 285 - 289
  • [50] Breast Cancer in Nepal: Current status and future directions
    Giri, Mohan
    Giri, Mamata
    Thapa, Rabin Jung
    Upreti, Bibhuti
    Pariyar, Bijay
    BIOMEDICAL REPORTS, 2018, 8 (04) : 325 - 329